A new Periodic Transaction Report filed under the STOCK Act shows Hon. Maria Elvira Salazar, a member of the U.S. House of Representatives, purchased shares of Merck & Company, Inc. Common Stock (MRK) on August 19, 2026. The transaction was made by Salazar herself, through a UBS IRA Account, and is disclosed in the $15,001 to $50,000 range. Our internal tracking system classifies this filing as a congress buy signal.
Periodic Transaction Reports like this one are required whenever a member of Congress, their spouse, or a dependent child buys or sells stocks, bonds, or other covered securities above a certain threshold. The filings don’t require members to explain their reasoning, and disclosure alone is not an indication of wrongdoing or advance knowledge of any particular development at the company.
A Notable Cross-Signal at Merck
What makes this filing worth flagging is timing. Within the same 30-day window, a company insider at Merck, Guindo Chirfi, reported a sale of MRK stock on August 13, 2026, valued at $1,350,000. Seeing a member of Congress purchase shares of the same company just days after a large insider sale is the kind of overlap our platform is built to surface — not because it proves anything about either party’s motives, but because it’s a data point worth having on record when the two disclosure streams intersect.
Insider sales happen for all sorts of routine reasons, including tax planning, diversification, and pre-scheduled trading plans, and congressional stock purchases are similarly driven by a wide range of personal financial decisions. Still, tracking these two disclosure types side by side gives readers a fuller picture of activity around a given ticker than either data source would provide alone.
Merck shares have drawn attention from institutional managers as well. Readers interested in how larger investment firms have positioned themselves in names like MRK can review our ongoing coverage of Soleus Capital Management, L.P.’s quarterly 13F portfolio moves, which tracks fund-level positioning disclosed separately from congressional and insider filings.
As with all Periodic Transaction Reports, this filing reflects a legally mandated disclosure rather than a recommendation or endorsement of any trading strategy. WhoIsBuyingNow.com will continue monitoring subsequent filings tied to Salazar’s UBS IRA Account and any further Merck-related insider activity as they become public.